5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with nitroglycerin in 1 studies
Studies (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Trials (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Recent Studies (post-2010) (5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide) | Studies (nitroglycerin) | Trials (nitroglycerin) | Recent Studies (post-2010) (nitroglycerin) |
---|---|---|---|---|---|
73 | 0 | 8 | 12,659 | 2,240 | 1,398 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhalla, S; Gulati, A; Rai, A | 1 |
1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and nitroglycerin
Article | Year |
---|---|
Endothelin ETA receptor antagonist did not affect development of tolerance to glyceryl trinitrate in rat.
Topics: Animals; Blood Pressure; Dansyl Compounds; Drug Tolerance; Endothelin A Receptor Antagonists; Heart Rate; Injections, Intravenous; Male; Nitroglycerin; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A | 2004 |